GE vs TMO: Which Is the Better Buy?
Side-by-side comparison of GE Aerospace and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
GE Aerospace · Industrials
$284.60
+22.9% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
GE has more upside to fair value
(+22.9%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GE |
TMO |
| Current Price |
$284.60 |
$462.60 |
| Fair Value Estimate |
$349.84 |
$509.20 |
| Upside to Fair Value |
+22.9%
|
+10.1%
|
| Market Cap |
$297.4B |
$171.9B |
| Forward P/E |
34.1x
|
25.1x
|
| EV / EBITDA |
27.9x
|
19.0x
|
| Price / Sales |
6.2x
|
3.8x
|
| Price / FCF |
39.8x
|
25.5x
|
| Revenue Growth YoY |
+24.7%
|
+6.2%
|
| Gross Margin |
34.8%
|
39.4%
|
| Operating Margin |
18.5%
|
17.8%
|
| Return on Equity |
46.4%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.51%
|
3.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
GE Aerospace is a leading player in the aerospace and defense industry, specializing in jet engines and propulsion technologies with a strong presence in commercial engines and defense propulsion segments. The company benefits from a high-quality management team led by CEO H. Lawrence Culp, Jr., who has extensive experience in operational transformation and aerospace leadership. Despite a premium…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
GE |
TMO |
| Zone Low |
$262.38 |
$381.90 |
| Zone High |
$297.36 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|